Efficient determination of optimised multi-arm multi-stage experimental designs with control of generalised error-rates

12/01/2017
by   Michael Grayling, et al.
0

Primarily motivated by the drug development process, several publications have now presented methodology for the design of multi-arm multi-stage experiments with normally distributed outcome variables of known variance. Here, we extend these past considerations to allow the design of what we refer to as an abcd multi-arm multi-stage experiment. We provide a proof of how strong control of the a-generalised type-I familywise error-rate can be ensured. We then describe how to attain the power to reject at least b out of c false hypotheses, which is related to controlling the b-generalised type-II familywise error-rate. Following this, we detail how a design can be optimised for a scenario in which rejection of any d null hypotheses brings about termination of the experiment. We achieve this by proposing a highly computationally efficient approach for evaluating the performance of a candidate design. Finally, using a real clinical trial as a motivating example, we explore the effect of the design's control parameters on the statistical operating characteristics.

READ FULL TEXT
research
11/28/2017

A two-stage Fisher exact test for multi-arm studies with binary outcome variables

In small sample studies with binary outcome data, use of a normal approx...
research
07/09/2020

Adding experimental treatment arms to Multi-Arm Multi-Stage platform trials in progress

Multi-Arm Multi-Stage (MAMS) platform trials are an efficient tool for t...
research
04/03/2020

Graphical approaches for the control of generalised error rates

When simultaneously testing multiple hypotheses, the usual approach in t...
research
04/12/2022

Familywise error rate control for block response-adaptive randomization

Response-adaptive randomization allows the probabilities of allocating p...
research
02/17/2020

Estimating the number and effect sizes of non-null hypotheses

We study the problem of estimating the distribution of effect sizes (the...
research
03/17/2021

Decision rules for identifying combination therapies in open-entry, randomized controlled platform trials

The design and conduct of platform trials have become increasingly popul...
research
12/20/2022

A Rigorous Framework for Automated Design Assessment and Type I Error Control: Methods and Demonstrative Examples (Working Paper)

We present a proof-by-simulation framework for rigorously controlling a ...

Please sign up or login with your details

Forgot password? Click here to reset